• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Euro Surveill. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe

Giuseppe

Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]


Eurosurveillance, Volume 17, Issue 4, 26 January 2012

Perspectives


Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe


J Mereckiene ()<SUP>1</SUP><SUP>,2</SUP>, S Cotter<SUP>1</SUP><SUP>,2</SUP>, J T Weber<SUP>3</SUP>, A Nicoll<SUP>4</SUP>, F D'Ancona<SUP>2</SUP><SUP>,5</SUP>, P L Lopalco<SUP>4</SUP>, K Johansen<SUP>4</SUP>, A M Wasley<SUP>6</SUP>, P Jorgensen<SUP>6</SUP>, D L?vy-Bruhl<SUP>2</SUP><SUP>,7</SUP>, C Giambi<SUP>2</SUP><SUP>,5</SUP>, P Stefanoff<SUP>2</SUP><SUP>,8</SUP>, L Dematte<SUP>2</SUP><SUP>,9</SUP>, D O?Flanagan<SUP>1</SUP><SUP>,2</SUP>, the VENICE project gatekeepers group<SUP>10</SUP>
  1. Health Protection Surveillance Centre, Dublin, Ireland
  2. Vaccine European New Integrated Collaboration Effort (VENICE) Project
  3. Centers for Disease Control and Prevention, Atlanta, United States
  4. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
  5. National Institute of Health (Istituto Superiore di Sanit?, ISS), Rome, Italy
  6. World Health Organization (WHO), Office for Europe, Copenhagen, Denmark
  7. French Institute for Public Health Surveillance (Institut de Veille Sanitaire, InVS), Saint-Maurice, France
  8. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland
  9. CINECA Consortium of University, Bologna, Italy
  10. Vaccine European New Integrated Collaboration Effort (VENICE) project gatekeepers group are listed at the end of the article
<HR>
Citation style for this article: Mereckiene J, Cotter S, Weber JT, Nicoll A, D'Ancona F, Lopalco PL, Johansen K, Wasley AM, Jorgensen P, L?vy-Bruhl D, Giambi C, Stefanoff P, Dematte L, O?Flanagan D, the VENICE project gatekeepers group. Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. Euro Surveill. 2012;17(4):pii=20064. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20064
Date of submission: 31 August 2011
<HR>In August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization.
- -------
 
Back
Top Bottom